The Role of Dysbiotic Oral Microbiota in Cardiometabolic Diseases: A Narrative Review
-
Published:2023-10-12
Issue:20
Volume:13
Page:3184
-
ISSN:2075-4418
-
Container-title:Diagnostics
-
language:en
-
Short-container-title:Diagnostics
Author:
Lê Sylvie123, Cecchin-Albertoni Chiara124, Thomas Charlotte123, Kemoun Philippe124, Minty Matthieu123, Blasco-Baque Vincent123
Affiliation:
1. Département Dentaire, Université Paul Sabatier III (UPS), 3 Chemin des Maraîchers, CEDEX 9, 31062 Toulouse, France 2. Service d’Odontologie Toulouse, CHU Toulouse, 3 Chemin des Maraîchers, CEDEX 9, 31062 Toulouse, France 3. Team InCOMM/Intestine ClinicOmics Metabolism & Microbiota, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC)—UMR1297 Inserm, Université Paul Sabatier, 1 Avenue Jean Poulhes, 31432 Toulouse, France 4. RESTORE Research Center, CNRS, EFS, ENVT, Batiment INCERE, INSERM, Université de Toulouse, 4 bis Avenue Hubert Curien, 31100 Toulouse, France
Abstract
Over the past decade, there have been significant advancements in the high-flow analysis of “omics,” shedding light on the relationship between the microbiota and the host. However, the full recognition of this relationship and its implications in cardiometabolic diseases are still underway, despite advancements in understanding the pathophysiology of these conditions. Cardiometabolic diseases, which include a range of conditions from insulin resistance to cardiovascular disease and type 2 diabetes, continue to be the leading cause of mortality worldwide, with a persistently high morbidity rate. While the link between the intestinal microbiota and cardiometabolic risks has been extensively explored, the role of the oral microbiota, the second-largest microbiota in the human body, and specifically the dysbiosis of this microbiota in causing these complications, remains incompletely defined. This review aims to examine the association between the oral microbiota and cardiometabolic diseases, focusing on the dysbiosis of the oral microbiota, particularly in periodontal disease. Additionally, we will dive into the mechanistic aspects of this dysbiosis that contribute to the development of these complications. Finally, we will discuss potential prevention and treatment strategies, including the use of prebiotics, probiotics, and other interventions.
Subject
Clinical Biochemistry
Reference77 articles.
1. Thomas, C., Minty, M., Vinel, A., Canceill, T., Loubières, P., Burcelin, R., Kaddech, M., Blasco-Baque, V., and Laurencin-Dalicieux, S. (2021). Oral Microbiota: A Major Player in the Diagnosis of Systemic Diseases. Diagnostics, 11. 2. Zhang, C., Sun, Y., Xu, M., Shu, C., Yue, Z., Hou, J., and Ou, D. (2022). Potential links between COVID-19 and periodontitis: A bioinformatic analysis based on GEO datasets. BMC Oral Health, 22. 3. Mainas, G., Nibali, L., Ide, M., Mahmeed, W.A., Al-Rasadi, K., Al-Alawi, K., Banach, M., Banerjee, Y., Ceriello, A., and Cesur, M. (2022). Associations between Periodontitis, COVID-19, and Cardiometabolic Complications: Molecular Mechanisms and Clinical Evidence. Metabolites, 13. 4. Microbiota succession throughout life from the cradle to the grave;Martino;Nat. Rev. Microbiol.,2022 5. Microbiota in health and diseases;Hou;Signal Transduct. Target. Ther.,2022
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|